2025-08-20 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY em_admin em_vitrification _em_admin.last_update _em_vitrification.instrument STRUCTURE_SUMMARY chem_comp_atom chem_comp_bond em_3d_fitting_list em_admin pdbx_entry_details pdbx_initial_refinement_model pdbx_modification_feature _em_3d_fitting_list.accession_code _em_3d_fitting_list.initial_refinement_model_id _em_3d_fitting_list.source_name _em_3d_fitting_list.type _em_admin.last_update EXPERIMENTAL_PREPARATION em_admin em_vitrification _em_admin.last_update _em_vitrification.instrument RCSB RCSB 2022-05-09 2022-07-06 2022-07-06 2025-08-20 National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) R35-GM118108 United States American Cancer Society 134255-PF-20-041-01-DMC United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) U24 GM129541 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) U24 GM129539 United States Staphylococcus epidermidis RP62a CRISPR tall effector complex Smith EM Ferrell SH Tokars VL Mondragon A Type IIIA CRISPR, effector complex, RNA binding protein, HYDROLASE-RNA complex Smith EM Ferrell S Tokars VL Mondragon A Structures of an active type III-A CRISPR effector complex. Structure UK 30 1109 1128.e6 2022 35714601 doi:10.1016/j.str.2022.05.013 0969-2126 2005 STRUE6 7uzz FULLOVERLAP EMDB EMD-26923 associated EM volume
Staphylococcus epidermidis RP62a CRISPR tall effector complex
 Staphylococcus epidermidis RP62a CRISPR tall effector complex Staphylococcus epidermidis RP62a CRISPR tall effector complex 0 1 2 3 4 5 6 Staphylococcus epidermidis RP62A RNA (37-MER) Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.011895168 1 ACGAGAACACGUAUGCCGAAGUAUAUAAAUCAUCAGU CRISPR system Cms protein Csm2 Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.015436793999999998 3 LEVO MTFAHEVVKSNVKNVKDRKGKEKQVLFNGLTTSKLRNLMEQVNRLYTIAFNSNEDQLNEEFIDELEYLKIKFYYEAGREK SVDEFLKKTLMFPIIDRVIKKESKKFFLDYCKYFEALVAYAKYYQKED Q5HK90 CRISPR system Cms protein Csm5 Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.039449125 1 LEVO MTIKNYEVVIKTLGPIHIGSGQVMKKQDYIYDFYNSKVYMINGNKLVKFLKRKNLLYTYQNFLRYPPKNPRENGLKDYLD AQNVKQSEWEAFVSYSEKVNQGKKYGNTRPKPLNDLHLMVRDGQNKVYLPGSSIKGAIKTTLVSKYNNEKNKDIYSKIKV SDSKPIDESNLAIYQKIDINKSEKSMPLYRECIDVNTEIKFKLTIEDEIYSINEIEQSIQDFYKNYYDKWLVGFKETKGG RRFALEGGIPDVLNQNILFLGAGTGFVSKTTHYQLKNRKQAKQDSFEILTKKFRGTYGKMKEIPSNVPVALKGTTNQSRH TSYQQGMCKVSFQELNNEVL Q5HK93 CRISPR system Cms endoribonuclease Csm3 Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.024033975 4 LEVO MYSKIKISGTIEVVTGLHIGGGGESSMIGAIDSPVVRDLQTKLPIIPGSSIKGKMRNLLAKHFGLKMKQESHNQDDERVL RLFGSSEKGNIQRARLQISDAFFSEKTKEHFAQNDIAYTETKFENTINRLTAVANPRQIERVTRGSEFDFVFIYNVDEES QVEDDFENIEKAIHLLENDYLGGGGTRGNGRIQFKDTNIETVVGEYDSTNLKIK Q5HK91 CRISPR system Cms protein Csm4 Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.034551938 1 LEVO MTLATKVFKLSFKTPVHFGKKRLSDGEMTITADTLFSALFIETLQLGKDTDWLLNDLIISDTFPYENELYYLPKPLIKID SKEEDNHKAFKKLKYVPVHHYNQYLNGELSAEDATDLNDIFNIGYFSLQTKVSLIAQETDSSADSEPYSVGTFTFEPEAG LYFIAKGSEETLDHLNNIMTALQYSGLGGKRNAGYGQFEYEIINNQQLSKLLNQNGKHSILLSTAMAKKEEIESALKEAR YILTKRSGFVQSTNYSEMLVKKSDFYSFSSGSVFKNIFNGDIFNVGHNGKHPVYRYAKPLWLEV Q5HK92 CRISPR system single-strand-specific deoxyribonuclease Cas10/Csm1 (subtype III-A) Staphylococcus epidermidis RP62A ATCC 35984 / RP62A 0.087685781 1 LEVO MNKKNILMYGSLLHDIGKIIYRSGDHTFSRGTHSKLGHQFLSQFSEFKDNEVLDNVAYHHYKELAKANLDNDNTAYITYI ADNIASGIDRRDIIEEGDEEYEKQLFNFDKYTPLYSVFNIVNSEKLKQTNGKFKFSNESNIEYPKTENIQYSSGNYTTLM KDMSHDLEHKLSIKEGTFPSLLQWTESLWQYVPSSTNKNQLIDISLYDHSRITCAIASCIFDYLNENNIHNYKDELFSKY ENTKSFYQKEAFLLLSMDMSGIQDFIYNISGSKALKSLRSRSFYLELMLEVIVDQLLERLELARANLLYTGGGHAYLLVS NTDKVKKKITQFNNELKKWFMSEFTTDLSLSMAFEKCSGDDLMNTSGNYRTIWRNVSSKLSDIKAHKYSAEDILKLNHFH SYGDRECKECLRSDIDINDDGLCSICEGIINISNDLRDKSFFVLSETGKLKMPFNKFISVIDYEEAEMLVQNNNQVRIYS KNKPYIGIGISTNLWMCDYDYASQNQDMREKGIGSYVDREEGVKRLGVVRADIDNLGATFISGIPEKYNSISRTATLSRQ LSLFFKYELNHLLENYQITAIYSGGDDLFLIGAWDDIIEASIYINDKFKEFTLDKLTLSAGVGMFSGKYPVSKMAFETGR LEEAAKTGEKNQISLWLQEKVYNWDEFKKNILEEKLLVLQQGFSQTDEHGKAFIYKMLALLRNNEAINIARLAYLLARSK MNEDFTSKIFNWAQNDKDKNQLITALEYYIYQIREAD Q5HK89 singleParticle particle 3.2 8.0 50.0 C4H11NO3 2-Amino-2-(hydroxymethyl)propane-1,3-diol 250.0 NaCl NaCl 1.0 C4H10O2S2 Dithiothreitol Homemade COPPER 300 CARBON HOLEY ARRAY GLOW DISCHARGE
Grids were glow discharged for 10 seconds with 12 mA current (Pelco easiGlow) prior to use on Chameleon.
 ETHANE 95 277 SPT LABTECH CHAMELEON
Grids were prepared at the National Center for CryoEM Access and Training (NCCAT) using a Chameleon (SPT Labtech) blotless system. 300 mesh nanowire grids with multi-hole pattern carbon film and a thin layer of gold coating (~ 5 nm) (SPT Labtech)were used.
TFS KRIOS OTHER BRIGHT FIELD FIELD EMISSION GUN 300 0.8 2.5 46772.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN GATAN K3 (6k x 4k) 6041 61.07 1 1982259 cryoSPARC PHASE FLIPPING AND AMPLITUDE CORRECTION C1 FOURIER SPACE 4.45 FSC 0.143 CUT-OFF cryoSPARC 101620 MAXIMUM LIKELIHOOD cryoSPARC MAXIMUM LIKELIHOOD cryoSPARC cryoSPARC emd_26923.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 208 208 208 0 0 0 208 208 208 444.7456 444.7456 444.7456 90.0 90.0 90.0 X Y Z -0.33699438 1.2992011 -0.00077354815 0.03778866 2.1382 2.1382 2.1382 0.21 AUTHOR 6NBT A PDB experimental model 6NBT B PDB experimental model 6NBT C PDB experimental model 6NBT D PDB experimental model 6NBU I PDB experimental model 6NBU J PDB experimental model 6NBU K PDB experimental model OTHER REAL emd_26923_msk_1.map emd_26923_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 208 208 208 0 0 0 208 208 208 444.7456 444.7456 444.7456 90.0 90.0 90.0 X Y Z -0.7223919 1.4179344 0.00065563014 0.08756297 2.1382 2.1382 2.1382 AUTHOR emd_26923_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 208 208 208 0 0 0 208 208 208 444.7456 444.7456 444.7456 90.0 90.0 90.0 X Y Z -0.6084987 1.5788841 0.0006712782 0.08762403 2.1382 2.1382 2.1382 AUTHOR